Patents Assigned to ViaCord, LLC
  • Patent number: 9072740
    Abstract: Methods of causing an improvement in central nervous system function are provided. The methods include administering an aliquot of stem cells to the patient, the cells being derived from blood, e.g., umbilical cord blood. In some cases a growth factor is administered with the cells.
    Type: Grant
    Filed: November 19, 2012
    Date of Patent: July 7, 2015
    Assignees: The General Hospital Corporation, ViaCord LLC
    Inventors: Morey Kraus, Seth Finklestein, Paul T. Clark
  • Publication number: 20140079673
    Abstract: The invention features a method for treating or preventing ischemia in a mammal by administering unrestricted somatic stem cells (USSCs) to the mammal.
    Type: Application
    Filed: November 19, 2013
    Publication date: March 20, 2014
    Applicant: ViaCord LLC
    Inventors: Andreas MUHS, Stephan WNENDT
  • Patent number: 8613906
    Abstract: The invention features a method for treating or preventing ischemia in a mammal by administering unrestricted somatic stem cells (USSCs) to the mammal.
    Type: Grant
    Filed: May 26, 2006
    Date of Patent: December 24, 2013
    Assignee: ViaCord, LLC
    Inventors: Andreas Muhs, Stephan Wnendt
  • Publication number: 20130142756
    Abstract: Methods of causing an improvement in central nervous system function are provided. The methods include administering an aliquot of stem cells to the patient, the cells being derived from blood, e.g., umbilical cord blood. In some cases a growth factor is administered with the cells.
    Type: Application
    Filed: November 19, 2012
    Publication date: June 6, 2013
    Applicants: The General Hospital Corporation, ViaCord, LLC
    Inventors: ViaCord, LLC, The General Hospital Corporation
  • Patent number: 8337833
    Abstract: Methods of causing an improvement in central nervous system function are provided. The methods include administering an aliquot of stem cells to the patient, the cells being derived from blood, e.g., umbilical cord blood. In some cases a growth factor is administered with the cells.
    Type: Grant
    Filed: May 11, 2010
    Date of Patent: December 25, 2012
    Assignees: The General Hospital Corp., ViaCord, LLC
    Inventors: Morey Kraus, Seth Finklestein, Paul Clark